ONWD Stock Overview
A medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Onward Medical N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.75 |
| 52 Week High | €6.58 |
| 52 Week Low | €1.85 |
| Beta | 0.79 |
| 11 Month Change | -20.03% |
| 3 Month Change | -0.84% |
| 1 Year Change | 35.33% |
| 33 Year Change | -61.88% |
| 5 Year Change | n/a |
| Change since IPO | -62.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| ONWD | BE Medical Equipment | BE Market | |
|---|---|---|---|
| 7D | -5.0% | -2.9% | -2.4% |
| 1Y | 35.3% | 12.8% | 3.5% |
Return vs Industry: ONWD exceeded the Belgian Medical Equipment industry which returned 13.2% over the past year.
Return vs Market: ONWD exceeded the Belgian Market which returned 3.7% over the past year.
Price Volatility
| ONWD volatility | |
|---|---|
| ONWD Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in BE Market | 6.3% |
| 10% least volatile stocks in BE Market | 2.3% |
Stable Share Price: ONWD's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: ONWD's weekly volatility has decreased from 13% to 6% over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 99 | Dave Marver | www.onwd.com |
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V. Fundamentals Summary
| ONWD fundamental statistics | |
|---|---|
| Market cap | €164.49m |
| Earnings (TTM) | -€35.15m |
| Revenue (TTM) | n/a |
-874.9x
P/S Ratio-4.7x
P/E RatioIs ONWD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ONWD income statement (TTM) | |
|---|---|
| Revenue | -€188.00k |
| Cost of Revenue | €13.44m |
| Gross Profit | -€13.63m |
| Other Expenses | €21.52m |
| Earnings | -€35.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | -1.02 |
| Gross Margin | 7,250.53% |
| Net Profit Margin | 18,697.34% |
| Debt/Equity Ratio | 87.3% |
How did ONWD perform over the long term?
See historical performance and comparison